Skip to main content

Live Teva Pharmaceutical Industries Limited Share Price Chart

O 42.75H 43L 42.62

Teva Pharmaceutical Industries Limited Performance Overview

Days Range
▼
$42.05Low
$43.04High

Markets Today

Previous Close$42.62
Open$42.80
Volume4,843,630
Day's Range$42.05 - $43.04
52W Range$37.00 - $43.34
Market Cap$49.73 B

Historical Performance

1M Returns+2.23
3M Returns+12.70
6M Returns+23.95
1Y Returns+72.79
5Y Returns+375.56
10Y Returns+8.84

Teva Pharmaceutical Industries Limited Fundamentals

Market Cap$49.73 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$17.26 B
ROE TTMN/A
EPS TTM$0.00
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$4.93 B
Profit Margin8.17
Market Cap$49.73 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$17.26 B
ROE TTMN/A
EPS TTM$0.00
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$4.93 B
Profit Margin8.17

Teva Pharmaceutical Industries Limited Profit & Loss

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Total Revenue +$4.18 B$4.48 B$4.71 B$3.98 B$4.14 B$4.39 B
Gross Profit +$2.10 B$2.30 B$2.65 B$1.97 B$2.15 B$2.44 B
Operating Income $455.00 M$882.00 M$299.00 M$652.00 M-$231.00 M$714.00 M
EBITDA $1.15 B$1.32 B$1.52 B$997.00 M$409.00 M$1.45 B
Interest Expense $0$0$0$0$0$0
Depreciation $691.00 M$435.00 M$1.23 B$345.00 M$640.00 M$735.00 M
Income Before Tax $203.00 M$646.00 M$80.00 M$437.00 M-$455.00 M$300.00 M
Income Tax Expense -$78.00 M$214.00 M-$390.00 M$67.00 M$121.00 M$66.00 M
Net Income +$282.00 M$434.00 M$481.00 M$370.00 M-$576.00 M$234.00 M
Net Profit Margin 6.75%9.69%10.21%9.29%-13.91%5.32%

Teva Pharmaceutical Industries Limited Financials Balance Sheet In USD

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Share Capital $58.00 M$58.00 M$58.00 M$59.00 M$59.00 M$59.00 M
Reserve & Surplus -$17.11 B-$16.72 B-$16.15 B-$15.91 B-$16.43 B-$16.29 B
Non-Current Liabilities $21.44 B$21.11 B$19.38 B$18.28 B$16.45 B$16.63 B
Current Liabilities $11.53 B$11.17 B$13.10 B$13.20 B$15.33 B$15.13 B
Total Liabilities $33.30 B$32.60 B$32.83 B$31.81 B$32.10 B$32.06 B
Fixed Assets $8.95 B$8.76 B$7.86 B$7.61 B$7.38 B$7.05 B
Current Assets $12.62 B$12.74 B$13.95 B$13.71 B$13.76 B$14.60 B
Total Assets $40.13 B$39.86 B$40.75 B$40.04 B$39.86 B$40.04 B

Teva Pharmaceutical Industries Limited Cash Flow

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Net Income $283.00 M$434.00 M$481.00 M$369.00 M-$575.00 M$234.00 M
Operating Cash Flow $227.00 M$369.00 M$1.16 B-$40.00 M$411.00 M$241.00 M
Investing Cash Flow $236.00 M$135.00 M$165.00 M$229.00 M-$491.00 M$210.00 M
Financing Cash Flow $6.00 M-$453.00 M$40.00 M$13.00 M-$1.00 M$5.00 M
Change in Cash $464.00 M$42.00 M$1.35 B$185.00 M-$86.00 M$430.00 M

Teva Pharmaceutical Industries Limited Peer Comparison

CompanyMarket Cap5 Years Return %PE RatioProfit Margin %Dividend Yield %
ABBV
$517.59B146.05%50.786.92%2.47%

Teva Pharmaceutical Industries Limited Return Calculator

The Teva Pharmaceutical Industries Limited stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$47,466
Invested Amount$10,000
Est. Returns$37,466
Invest in USA Stock Today

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

FAQs

Teva Pharmaceutical Industries Limited (TEVA) share price as of November 19, 2026 is $42.15. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Teva Pharmaceutical Industries Limited (TEVA) Share by opening an international trading account with Angel One.
Purchasing Teva Pharmaceutical Industries Limited (TEVA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Teva Pharmaceutical Industries Limited (TEVA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Teva Pharmaceutical Industries Limited (TEVA) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Teva Pharmaceutical Industries Limited on November 19, 2026, is $49.73 B.
Teva Pharmaceutical Industries Limited operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Teva Pharmaceutical Industries Limited (TEVA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.